American Healthcare REIT, Inc. (NYSE: AHR) disclosed that one of its directors, Scott A. Estes, sold 2,500 shares of the company's common stock on November 10, 2026. The shares were sold at a price of $59.32 per share, resulting in a total transaction value of $148,300.
The sale took place as the stock trades near its 52-week high of $59.53. Year-to-date, shares of American Healthcare REIT have delivered a strong return of 28%. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value, placing it among companies on the Most Overvalued list.
Following this transaction, Mr. Estes directly holds 18,989 shares of American Healthcare REIT common stock. For deeper insights into AHR's valuation and performance, investors can access a comprehensive Pro Research Report, available for this and more than 1,400 other US equities on InvestingPro.
In other recent news, American Healthcare REIT reported strong third-quarter results, with normalized funds from operations increasing by 31.8% to $0.58 per diluted share compared to the previous year. The company also announced revenue of $742.15 million and raised its full-year outlook, highlighting robust performance across its senior housing and skilled nursing platforms. Additionally, American Healthcare REIT launched a $1.75 billion at-the-market equity program, allowing for the sale of common stock through various financial institutions based on market conditions.
RBC Capital raised its price target for American Healthcare REIT to $66 from $61, maintaining an Outperform rating and increasing its funds from operations estimates for 2026, 2027, and 2028. Similarly, Raymond James increased its price target to $72 from $62, maintaining a Strong Buy rating, which reflects confidence in the company's position within the senior housing sector. These developments underscore American Healthcare REIT's growth outlook and platform strength.